Alteromonas haloplanktis strain SB-1123 isolated from deep-sea mudproduced a new siderophore, bisucaberin. Bisucaberin rendered tumor cells susceptible to cytolysis mediated by murine peritoneal macrophages which were elicited by Proteose peptone and not yet activated by lymphokine. Bisucaberin exerted its sensitizing activity by both the preincubation with tumor cells and the addition to co-culture of macrophagesand tumor cells. The activity of bisucaberin was specifically inhibited by ferric ion. Bisucaberin showed direct cytostasis for tumor cells but did not cause cytolysis in the absence of macrophages. Cytostasis by bisucaberin was attributable to the specific inhibition of DNAsynthesis in tumor cells.
Alteromonas haloplanktis strain SB-1123 isolated from deep-sea mudproduced a new siderophore, bisucaberin. Bisucaberin rendered tumor cells susceptible to cytolysis mediated by murine peritoneal macrophages which were elicited by Proteose peptone and not yet activated by lymphokine. Bisucaberin exerted its sensitizing activity by both the preincubation with tumor cells and the addition to co-culture of macrophagesand tumor cells. The activity of bisucaberin was specifically inhibited by ferric ion. Bisucaberin showed direct cytostasis for tumor cells but did not cause cytolysis in the absence of macrophages. Cytostasis by bisucaberin was attributable to the specific inhibition of DNAsynthesis in tumor cells.
Macrophagesshow tumoricidal activity in vitro and are regarded as cytotoxic effectors against neoplastic cells in vivo.1"0 Recently, several agents containing antitumor antibiotics have been found to augment cytotoxicity in effector-target systems in vitro.*"® Therefore, we have screened substances causing cytolysis of tumor cells in co-culture with macrophages which do not lyse tumor cells by themselves. These substances can be candidates for antitumor agents. In this screening system, we found a novel siderophore and designated it bisucaberin. "Siderophore" is a general term for bacterial low MWiron chelators.9) Physico-chemical properties and structural determination of bisucaberin will be described in a accompanying paper.10) This report describes identification of the producer and isolation and biological properties of bisucaberin.
Materials and Methods

Materials
Radiolabeled precursors, [me^j>/-3H]thymidine (specific activity, 5 Ci/mmol), [6-3H] uridine (specific activity, 20 Ci/mmol) and L-[4,5-3H(N)]leucine (specific activity, 60 Ci/mmol), were purchased from Arnersham Japan Co., Tokyo, Japan. Nocardamine was kindly donated from Dr. W. KellerSchierlein, Eidgenossischen Technishcen Hochschule, Zurich, Switzerland.
Lymphokine wasobtained from the culture supernatant of murinespleen cells stimulated with concanavalin A according to the method of Boraschi et al.lD The Producing Organism The bisucaberin producing organism, strain SB-1123, was isolated from deep-sea mud collected at about 3,300 m in depth off the coast of Aomori Prefecture. This mud was kindly donated by Japan Marine Science and Technology Center, Kanagawa, Japan. Identification of this strain was performed Fibrosarcoma 1023, a tumorigenic tumor cell line was kindly donated by Dr. T. Tokunaga, National Institute of Health, Tokyo, Japan. This cell line had been induced in a C3H/HeNicr male mouse with 3-methylcholanthrene and has been maintained in culture with Dulbecco's modified Eagle's medium supplemented with 10 % fetal bovine serum (FBS). 13) L1210and IMCcarcinoma were cultured with Eagle's minimumessential mediumand RPMI 1640 medium, respectively, supplemented with 10 % FBS. Fermentati on Fermentation medium consisted of dried sardine powder 20 g, dried cuttlefish powder 10 g, maltose 5 g and CaCO32 g in 1 liter of the half strength synthetic sea water (Jamarin S, Jamarin Lab., Osaka, Japan). A loopful of slant culture of strain SB-1123 was inoculated into Erlenmeyer flasks (500-ml) containing 100 ml of the fermentation mediumand cultured at 27°C for 3 days on a rotary shaker (180 rpm).
Purification
Bisucaberin was isolated from fermentation broth as outlined in Fig. 1 . The culture filtrate was applied to Diaion HP-20 column chromatography and the active eluate was obtained with 50% aq Me2CO.Further purification was carried out by column chromatography on Diaion CHP-20P eluting with a linear gradient of aq Me2CO(0~20%) followed by column chromatography on silica gel eluting with CHC13-MeOH(96 :4). The active substance thus obtained was crystallized from hot MeOHto yield pure bisucaberin.
Preparation of Murine Peritoneal Macrophages
Murine peritoneal macrophages were used as effector cells in cytolysis assay. Female C3H/ HeNCrj mice (Charles River Japan Inc., Kanagawa, Japan) of 8 weeks-old were injected ip with 1.6 ml of 10% Proteose peptone, Difco. Peritoneal cavities were washed twice with 6 ml of Ca2+, Mg2+-free Dulbecco's phosphate buffered saline 3 days later. Peritoneal exudate cells thus obtained were pipetted into 96-well microtiter plates at the density of 2 x lO5 cells/well. Non-adherent cells were DEC. 1987 washed out with RPMI1640 medium 2 hours later. RPMI1640 medium supplemented with 100 u/ml benzylpenicillin, 100^g/ml streptomycin, 10% FBS and 10 mMJV-2-hydroxyethylpiperazine-AT/-2-ethansulfonic acid was used as the complete mediumunless otherwise noted.
Cytolysis Assay Fibrosarcoma 1023 was used as target cells in cytolysis assay. Target cell monolayer (3 to 4 x 106 cells/75 cm2 flask in 15 ml of the complete medium) was prelabeled with 5 jbtCi of [3H]thymidine for 18 hours. Labeled target cells were harvested by treating with trypsin-EDTA, washed with RPMI 1640 medium and then resuspended in the complete mediumto 1 x lO5 viable cells/ml. Cell suspension (100 jul) was added to culture wells containing the macrophage monolayer described above. Bisucaberin was added to each culture well and was present throughout the co-culture. Because bisucaberin is insoluble or hardly soluble in water and most organic solvents,1*0 it was dissolved in dimethyl sulfoxide followed by dilution with RPMI 1640 medium. Dimethyl sulfoxide itself was inactive under these conditions. Release of incorporated [3H]thymidine from prelabeled tumor cells was measured by liquid scintillation counting 2 days later. Maximumrelease was estimated by solubilizing with 0.5 % sodium dodecyl sulfate. Spontaneous release was estimated by culturing target cells alone and did not exceed 10%of maximumrelease in the series of experiments reported here. Results were expressed as follows :
\ specific lysis= Experimental release (dpm) -Spontaneous release (dpm)
Maximumrelease (dpm) -Spontaneous release (dpm) Radiolabeled Precursor Incorporation into TumorCells xlOO Exponentially growing tumor cells (2 x lO4 cells/microtiter well) were preincubated for 4 hours with bisucaberin in the complete medium. The cells were then pulse-labeled for 1 hour with [3H]-thymidine (2 juCi/ml), [3H]uridine (2^Ci/ml) or [3H]leucine (6^Ci/ml), separately. After washing of each well, tumor cells were harvested and the radioactivity incorporated into acid-insoluble fraction was measured by liquid scintillation counting. Results were expressed as % incorporation against that of un-preincubated cells.
Cell Growth and Viability
Exponentially growing tumor cells (2 x 104 cells/microtiter well) were cultured for 48 hours with bisucaberin. Cell growth was measured by a Coulter counter after dilution with saline.
Cell viability was assessed by exclusion of 0.2% trypan blue.14)
Results
Identification of the Producer Strain SB-1 123 was a typical marine bacteria requiring a seawater base for growth. It was Gramnegative aerobic rod and motile with polar-flagella.
The DNAG+C content was 44.1 mol%. These characteristics were identical to those of the genus Alteromonas. Strain SB-1 123 did not grow at 4°C.
It utilized D-mannose, sucrose, JV-acetylglucosamine, succinate, fumarate and citrate, and did not utilize erythritol, glycerol, D-sorbitol, DL-malate and a-ketoglutarate. It did not produce soluble pigment in all media tested. These characteristics were identical to those of Alteromonas haloplanktis, distinguishing them from other species of Alteromonas. Other cultural and physiological characteristics also conformed except for the utilization of aconitate. Therefore, strain SB-1 123 was identified as Alteromonas haloplanktis. This strain was deposited in Fermentation Research Institute of the Agency of Industrial Science and Technology, Japan with accession number of FERM-P88O3.
Fermentation and Purification of Bisucaberin Strain SB-1123 grew well in the fermentation medium and reached stationary phase after 2 days culture. Bisucaberin-production was proportional to growth. Twomarine products in the fermentation medium,sardine and cuttlefish, were essential to bisucaberin production. Seven liters of culture filtrate was subjected to the purification process and 2 g of crude crystals was obtained.
Induction of Macrophage-mediated Tumor Cell Lysis by Bisucaberin
The addition of bisucaberin to macrophage-tumor cell co-culture induced strong tumor cell lysis (Fig. 2) . Macrophages alone did not lyse tumor cells in the absence of bisucaberin. Induced lysis was dependent on bisucaberin concentration and reached the maximumat 18^g/ml of bisucaberin. Bisucaberin itself induced little cytolysis of tumor cells without macrophages at this concentration. At higher than 1 8^g/ml, macrophage-mediated cytolysis was diminished, while some direct cytotoxicity to tumor cells wasobserved.
Bisucaberin bound to ferric ion by the addition of FeCl3 and, consequently, turned red and became quite soluble in water. Ferric-bisucaberin induced only slight cytolysis in macrophage-tumor cell co-culture even at 54 /*g/ml. Nocardamine, a trihydroxamate siderophore desferrioxamine E, induced no cytolysis in co-culture in spite of structural similarity to bisucaberin.
Dependence of Bisucaberin-induced Cytolysis on E/T Ratio The effects of varying the ratio of effector to target cells (E/T ratio) was examined. Bisucaberininduced cytolysis of tumor cells was proportional to E/T ratio of macrophage-tumor cell co-culture
and reached the plateau at the ratio of ten or more (Fig. 3 ). Even at low E/T ratio (1/1), bisucaberin induced macrophage-mediated cytolysis of tumor cells to some extent.
Effects of Treatment Condition on Cytolysis Macrophages and tumor cells were separately preincubated with 18^g/ml of bisucaberin and co-cultured with the untreated counterpart cells in the absence of bisucaberin. When3H-labeled tumor cells were preincubated with bisucaberin for 18 hours, they were strongly lysed by the co-culture with macrophages ( Fig. 4(B) ). On the contrary, preincubation of macrophages with bisucaberin for 4 hours did not induce tumor cell lysis in the co-culture. These macrophages were able to be activated by lymphokine under the same condition. Prolonged preincubation of macrophages was also ineffective. When3H-labeled tumor target cells were mixed with equal amount of cold tumor cells preincubated with bisucaberin, incorporated radiolable was not released by the co-culture with macrophages (data not shown). The cytolysis was also induced by the addition of bisucaberin 1 day after the beginning of the co-culture (Fig. 4(Q) . Macrophages at this stage no longer primed for lymphokine activation.
Effects of Bisucaberin on the Macromolecular Synthesis of TumorCells After 4 hours preincubation of tumor cells with bisucaberin, the incorporation of [3H]thymidine was specifically inhibited in a dose-dependent manner (Fig. 5) . The inhibition reached nearly 80% at 18 jug/ml of bisucaberin. Leucine incorporation was also inhibited but its inhibition was lower by about one order of magnitude than that of thymidine. Uridine incorporation was not affected by bisucaberin in concentration ranging from 0.7 to 54^g/ml.
Cytostatic Effects of Bisucaberin on Tumor Cell Growth
Tumor cell growth for 48 hours was measured in the presence of bisucaberin (Table 1) . Bisuca-berin inhibited the growth of fibrosarcoma 1023. The inhibition reached 85% at 18^g/ml of bisucaberin. This was also the case of growth of other two tumors, L1210 and IMCcarcinoma, IC50 of bisucaberin for these tumor cells were 3.9^g/ml and 5.1 /Wg/ml, respectively. On the other hand, cell viability was not affected by bisucaberin. More than 98%of fibrosarcoma 1023 was viable with up to 18^g/ml of bisucaberin. At 54 A«g/ml, nonviable cells increased to 10 to 15%.
Discussion
Peptone elicited macrophages used in this study were not tumoricidal unless they had been activated by macrophage activating factors such as lymphokines, lipopolysaccharides, etc. Bisucaberin induced strong lysis of tumor cells co-cultured with these nonactivated macrophages. Induced cytolysis was mediated by macrophages because tumor cells cultured with bisucaberin alone remained their viability and did not show significant lysis except at an excess of bisucaberin. High concentration of bisucaberin showed some direct cytotoxicity to tumor cells, but also seemed to be toxic for macrophages to decrease net lysis of tumor cells. Macrophagemediation was supported by the dependenceof the cytolysis on E/T ratio.
Bisucaberin exerted its effect by sensitizing tumor cells to lysis by nonactivated macrophages and not by activating macrophages to be tumoricidal: Preincubation of tumor cells with bisucaberin was substitutive for the addition of bisucaberin to macrophage-tumor cell co-culture, but preincubation of macrophageswasnot. Furthermore, activation of macrophagesor stabilization of macrophagecytotoxic factor by bisucaberin which would leak out of preincubated tumor cells can be ruled out by that no cytolysis was occurred when3H-labeled and un-preincubated tumor cells were mixed with nonlabeled and bisucaberin-preincubated ones and then co-cultured with macrophages. Bisucaberin may substitute for one of tumoricidal mechanisms which are present in activated macrophages but not in nonactivated ones. Hibbs et al. reported release of intracellular iron content from tumor cells cocultured with activated macrophages and consequent inhibition of mitochondrial respiration.15»16) This maybe correlated with the bisucaberin-induced sensitization of tumor cells to macrophagemediated cytolysis.
That the sensitization of tumor cells to cytolysis is due to iron-chelation by bisucaberin seems apparent because ferric-bisucaberin was inactive. Nocardamine was also inactive although its structure closely resembles that of bisucaberin except for increase of hydroxamate residues from two to three. This suggests that extracellular chelation of iron is not responsible for the induction of cytolysis. Bergeron et al. suggested that the rate of transmembrane movementis important to the activity of spermidine catecholamine iron chelators.17) Nocardamine maymoveslowly across the cellular membranebecause of its larger molecular weight than that of bisucaberin and therefore does not induce cytolysis. This may be the case of ferric-bisucaberin.
Binding of ferric ion made bisucaberin quite soluble in water and possibly resulted in the formation of a large molecular complex. These changes may diminish the rate of trans-membrane movement of bisucaberin. The participation of intracellular iron-chelation in sensitizing tumor cells to macrophage-mediated cytolysis needs further investigation.
Bisucaberin seems to be a candidate for antitumor activity because 1) toxicity of bisucaberin for macrophages is relatively low; 2) sensitization of tumor cells by bisucaberin is so effective that a small number of macrophages can lyse these cells; 3) cytolysis can be induced even if bisucaberin is later added to macrophage-tumor cell co-culture. These features lead to an expectation that bisucaberin renders tumors susceptible in vivo to killing by tumor-associated macrophages.18)
